Inventor
HANSEN HENRIK FRYDENLUND
DK27 patents
⚠️ This page may combine multiple inventors who share the name “HANSEN HENRIK FRYDENLUND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE INNOVATION CT COPENHAGEN AS
8 patentsUS9708614B2Jul 18, 2017
Antisense design
ROCHE INNOVATION CT COPENHAGEN AS28 citations97
US10077443B2Sep 18, 2018
Oligonucleotide conjugates
ROCHE INNOVATION CT COPENHAGEN AS10 citations83
US9994850B2Jun 12, 2018
Antisense design
ROCHE INNOVATION CT COPENHAGEN AS4 citations83
US9951333B2Apr 24, 2018
Antisense design
ROCHE INNOVATION CT COPENHAGEN AS0 citations51
US9890383B2Feb 13, 2018
Antisense design
ROCHE INNOVATION CT COPENHAGEN AS0 citations51
US10815481B2Oct 27, 2020
Chiral library screen
ROCHE INNOVATION CT COPENHAGEN AS0 citations49
US9938527B2Apr 10, 2018
Potent LNA oligonucleotides for the inhibition of HIF-1A expression
ROCHE INNOVATION CT COPENHAGEN AS0 citations49
US11597926B2Mar 7, 2023
Thiophosphoramidites
ROCHE INNOVATION CT COPENHAGEN AS0 citations44
SANTARIS PHARMA AS
4 patentsUS7687617B2Mar 30, 2010
Oligonucleotides with alternating segments of locked and non-locked nucleotides
SANTARIS PHARMA AS207 citations98
US9428534B2Aug 30, 2016
Antisense design
SANTARIS PHARMA AS46 citations97
US6858726B2Feb 22, 2005
Synthesis of allofuranose
SANTARIS PHARMA AS2 citations62
US9447138B2Sep 20, 2016
Potent LNA oligonucleotides for the inhibition of HIF-1a expression
SANTARIS PHARMA AS1 citations52